Profund Advisors LLC Rocket Pharmaceuticals, Inc. Transaction History
Profund Advisors LLC
- $2.59 Billion
- Q3 2024
A detailed history of Profund Advisors LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 25,725 shares of RCKT stock, worth $276,286. This represents 0.02% of its overall portfolio holdings.
Number of Shares
25,725
Previous 22,201
15.87%
Holding current value
$276,286
Previous $477,000
0.42%
% of portfolio
0.02%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding RCKT
# of Institutions
211Shares Held
93.1MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$190 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$121 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$66.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$59.5 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$48.3 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $813M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...